William Creasman to Administration, Oral
This is a "connection" page, showing publications William Creasman has written about Administration, Oral.
Connection Strength
0.021
-
A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma. Am J Obstet Gynecol. 1979 Nov 01; 135(5):647-50.
Score: 0.010
-
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4.
Score: 0.008
-
Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986 Mar; 67(3):326-30.
Score: 0.004